953 Indiana street
San Francisco, CA 94107
415 849 5928
Alaunus Biosciences is a preclinical-stage immune-oncology company using a proprietary technology platform to address unmet clinical needs in cancer diagnosis and treatment We take advantage of the unique protease activity signature present in the tumor microenvironment, and leverage it to develop protease-activated cancer therapeutics and protease-based prognostic biomarkers.
We are initially focusing our technology on developing a laboratory-based assay for risk stratification and early detection of pancreatic cancer, by identifying pre-malignant cysts in the pancreas before they develop into full tumors.